Riggs Asset Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-36
Closed -$6K – 337
2022
Q2
$6K Sell
36
-23
-39% -$4.12K ﹤0.01% 230
2022
Q1
$10K Hold
59
– – ﹤0.01% 232
2021
Q4
$12K Buy
59
+46
+354% +$9.51K ﹤0.01% 233
2021
Q3
$3K Buy
+13
New +$3.2K ﹤0.01% 287
2020
Q3
– Sell
-3
Closed – – 209
2020
Q2
$0 Buy
+3
New +$275 ﹤0.01% 264

Other funds holding MED

Riggs Asset Management's MED Position: Q3 2022 in Review

Riggs Asset Management sold out of Medifast (MED) in Q3 2022, closing a stake of 36 shares — an estimated $6K sold.

Riggs Asset Management first reported a position in MED in Q2 2020 and held it in 5 quarters. The position peaked at $12K in Q4 2021. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • Riggs Asset Management reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • Riggs Asset Management sold 36 Medifast shares in Q3 2022, an estimated $6K.
  • Riggs Asset Management first reported a position in Medifast in Q2 2020 and held it in 5 quarters.
  • Riggs Asset Management's Medifast position peaked at $12K in Q4 2021.
  • 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on Riggs Asset Management's 13F filing for Q3 2022, filed 9 Nov 2022.